Transgene SA
Transgene SA, a biotechnology company, focuses on designing and developing therapeutic vaccines and oncolytic viruses for the treatment of cancer and infectious diseases. It is involved in developing TG4050, a therapeutic vaccine that is in phase I clini…
Biotechnology
FR, Illkirch-Graffenstaden [HQ]
Cash Flow Statements
15 Records · Starting from 2009In Million EUR. Margins, Growth Rates In %
| Metric | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||||
| Operating Cash Flow (OCF) | -18.00 | -24.00 | -44.00 | -51.00 | -50.00 | -54.00 | -45.00 | -33.00 | -35.00 | -28.00 | -22.00 | -28.00 | -31.00 | -20.00 | -34.00 | |
| Operating Cash (Net) | -18.00 | -24.00 | -44.00 | -51.00 | -50.00 | -54.00 | -45.00 | -33.00 | -35.00 | -28.00 | -22.00 | -28.00 | -31.00 | -20.00 | -34.00 | |
| Accounts Receivable | - - | - - | - - | -1.00 | - - | - - | - - | -3.00 | -2.00 | -3.00 | -7.00 | -5.00 | -14.00 | 7.00 | -3.00 | |
| Accounts Payable | - - | - - | - - | - - | - - | - - | -1.00 | -2.00 | -1.00 | 2.00 | 2.00 | -2.00 | 2.00 | - - | -2.00 | |
|
Working Capital
|
- - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Change | 4.00 | 5.00 | -5.00 | -11.00 | -12.00 | -12.00 | -3.00 | -17.00 | -9.00 | -2.00 | -1.00 | -8.00 | -12.00 | 5.00 | -7.00 | |
| Other WC | 4.00 | 5.00 | -5.00 | -11.00 | -12.00 | -11.00 | -3.00 | -18.00 | -9.00 | -2.00 | 4.00 | -1.00 | - - | -1.00 | - - | |
| Investing Activities | ||||||||||||||||
| Used Cash (Net) | -4.00 | -7.00 | -5.00 | -4.00 | -4.00 | - - | 2.00 | -2.00 | - - | -1.00 | - - | 17.00 | 16.00 | 20.00 | 34.00 | |
| Capital Expenditure | -4.00 | - - | -3.00 | -1.00 | -2.00 | -2.00 | -1.00 | - - | - - | -1.00 | -1.00 | - - | - - | -1.00 | -2.00 | |
| Purchases of Investments | - - | - - | - - | - - | - - | - - | - - | -2.00 | - - | - - | - - | -18.00 | -40.00 | - - | - - | |
| Sale/Maturity of Investment | - - | - - | - - | - - | - - | - - | 3.00 | - - | - - | - - | 1.00 | 18.00 | 17.00 | 21.00 | 37.00 | |
| Property, Plant, Equipment (P&PE) | -4.00 | - - | -3.00 | -1.00 | -2.00 | -2.00 | -1.00 | - - | - - | -1.00 | -1.00 | - - | - - | -1.00 | -2.00 | |
| Acquisitions (Net) | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | 18.00 | 17.00 | - - | 14.00 | |
| Other Investing Activities | - - | -7.00 | -1.00 | -2.00 | -2.00 | 3.00 | 3.00 | -2.00 | - - | - - | 1.00 | - - | 22.00 | 21.00 | -14.00 | |
| Financing Activities | ||||||||||||||||
| Used Cash (Net) | - - | -30.00 | -50.00 | -60.00 | -53.00 | -52.00 | -42.00 | -37.00 | -32.00 | -30.00 | -22.00 | -14.00 | -15.00 | -1.00 | -11.00 | |
| Debt Repayment | - - | - - | - - | - - | -6.00 | -7.00 | - - | -8.00 | -1.00 | - - | -2.00 | -11.00 | - - | -1.00 | -12.00 | |
| Dividends Paid | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
|
Common Stock
|
- - | 156 | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Issued | - - | 152.00 | - - | - - | - - | 65.00 | - - | 46.00 | 14.00 | - - | 48.00 | - - | 34.00 | - - | - - | |
| Repurchased | - - | -4.00 | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Other Financing Activities | - - | -179.00 | 49.00 | 59.00 | 53.00 | -13.00 | 42.00 | -9.00 | 18.00 | 30.00 | -23.00 | 26.00 | -18.00 | - - | 12.00 | |
| Cash Balances | ||||||||||||||||
| Begin of Period | 86.00 | 64.00 | 1.00 | 1.00 | 6.00 | 5.00 | 3.00 | 3.00 | 4.00 | 1.00 | 1.00 | 1.00 | 5.00 | 5.00 | 4.00 | |
| End of Period | 64.00 | 1.00 | 1.00 | 6.00 | 5.00 | 3.00 | 3.00 | 4.00 | 1.00 | 1.00 | 1.00 | 5.00 | 5.00 | 4.00 | 15.00 | |
| Change | -22.00 | -63.00 | - - | 4.00 | - - | -1.00 | - - | 1.00 | -3.00 | - - | - - | 3.00 | - - | -1.00 | 11.00 | |
| Non-Cash Balances | ||||||||||||||||
| Depreciation and Amortization | 3.00 | 2.00 | 2.00 | 2.00 | 2.00 | 3.00 | 2.00 | 2.00 | 1.00 | 1.00 | - - | 1.00 | 2.00 | 1.00 | 1.00 | |
| Stock Based Compensation | - - | 1.00 | 1.00 | - - | - - | - - | - - | - - | - - | - - | 1.00 | 1.00 | 3.00 | 2.00 | - - | |
| Other | - - | - - | - - | - - | - - | 1.00 | - - | 5.00 | 2.00 | -33.00 | -5.00 | -7.00 | -4.00 | 3.00 | 2.00 | |
| Highlighted metrics | ||||||||||||||||
| Free Cash Flow (FCF) | -22.00 | -25.00 | -48.00 | -53.00 | -52.00 | -56.00 | -46.00 | -33.00 | -35.00 | -29.00 | -24.00 | -29.00 | -32.00 | -21.00 | -37.00 | |
| Cash Conversion Cycle (CCC) | 9.00 | 4,666.00 | -51.00 | 191.00 | 994.00 | 1,603.00 | 3,787.00 | 1,970.00 | 334.00 | 156.00 | 154.00 | 229.00 | 327.00 | 531.00 | 394.00 | |
| Invested Capital | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
|
Other Operating Inflows/Outflows
|
||||||||||||||||
| Forex Effect on Cash | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - |